文献速递前列腺癌

基于多参数磁共振与ISUP分级的前列腺癌盆腔淋巴结清扫预测工具开发与外部验证

Development and External Validation of a Multiparametric Magnetic Resonance Imaging and International Society of Urological Pathology Based Add-On Prediction Tool to Identify Prostate Cancer Candidates for Pelvic Lymph Node Dissection.
PubMed 文献 · J Urol · 2019-11-13

本研究开发并外部验证了一个用于预测前列腺癌患者淋巴结侵犯的工具,纳入多参数磁共振肿瘤分期和活检ISUP分级等信息。开发队列420例,外部验证队列187例,预测准确性内部交叉验证为79.7%,外部验证为72.5%。该工具回应了从系统活检向靶向活检的范式转变。

要点

  • 预测工具纳入PSA、mpMRI T分期、单针最大肿瘤长度和最高ISUP分级组。
  • 开发队列淋巴结侵犯率16.9%,预测准确性内部79.7%、外部72.5%。
  • 该工具纳入核心特异性活检信息,替代阳性针数百分比,适应靶向活检时代。

核心结论

  • 报告了一个当代的、经外部验证的前列腺癌淋巴结侵犯预测工具。

研究设计与样本

  • 开发队列420例,外部验证队列187例,均为接受根治性前列腺切除术加扩大盆腔淋巴结清扫、且有ISUP活检分级和mpMRI信息的患者。

主要发现

  • 开发队列中每例患者中位切除21枚淋巴结,71例(16.9%)诊断为淋巴结侵犯。
  • 淋巴结侵犯的显著预测因素包括初始PSA值、mpMRI基于的T分期、单针最大肿瘤长度(mm)和对应单针最大肿瘤侵犯的ISUP分级组。
  • 预测准确性在五折内部交叉验证后为79.7%,外部验证后为72.5%。

临床怎么用

  • 该工具可辅助识别前列腺癌患者中适合接受盆腔淋巴结清扫的候选者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We sought to expand current prediction tools for lymph node invasion in patients with prostate cancer using current state-of-the-art available tumor information, including multiparametric magnetic resonance imaging based tumor stage and detailed biopsy information. MATERIALS AND METHODS: We selected patients with prostate cancer for study who had available registered information on ISUP (International Society of Urological Pathology) based biopsy grading and multiparametric magnetic resonance imaging, and who had undergone radical prostatectomy with extended pelvic lymph node dissection. We developed a lymph node invasion prediction tool in 420 patients and externally validated it in 187. A concordance index was estimated to quantify the discriminative performance of the model. RESULTS: In the development cohort a median of 21 lymph nodes were removed per patient and 71 patients (16.9%) were diagnosed with lymph node invasion. Statistically significant predictors of lymph node invasion were the initial prostate specific antigen value, multiparametric magnetic resonance imaging based T stage, maximum tumor length in 1 core in mm and ISUP grade group corresponding to the maximum tumor involvement in 1 core. The predictive accuracy of this lymph node invasion prediction tool was 79.7% after fivefold internal cross validation and 72.5% after external validation. CONCLUSIONS: We report a contemporary, externally validated prediction tool for lymph node invasion in patients with prostate cancer. This prediction tool is a response to the paradigm shift from systematic to targeted biopsies by incorporating additional core specific biopsy information instead of the percent of positive cores. This new tool will also overcome stage migration, which is a potential risk when multiparametric magnetic resonance imaging information is used in digital rectal examination based nomograms.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Draulans C, Everaerts W, Isebaert S, et al. Development and External Validation of a Multiparametric Magnetic Resonance Imaging and International Society of Urological Pathology Based Add-On Prediction Tool to Identify Prostate Cancer Candidates for Pelvic Lymph Node Dissection. J Urol. 2019. PMID: 31718396. doi:10.1097/JU.0000000000000652

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。